You are here

PloS one DOI:10.1371/journal.pone.0103325

Identification of ALK Gene Alterations in Urothelial Carcinoma.

Publication TypeJournal Article
Year of Publication2014
AuthorsBellmunt, J, Selvarajah, S, Rodig, S, Salido, M, de Muga, S, Costa, I, Bellosillo, B, Werner, L, Mullane, S, Fay, AP, O'Brien, R, Barretina, J, Minoche, AE, Signoretti, S, Montagut, C, Himmelbauer, H, Berman, DM, Kantoff, P, Choueiri, TK, Rosenberg, JE
JournalPloS one
Volume9
Issue8
Pagese103325
Date Published2014/01/01
Abstract

Anaplastic lymphoma kinase (ALK) genomic alterations have emerged as a potent predictor of benefit from treatment with ALK inhibitors in several cancers. Currently, there is no information about ALK gene alterations in urothelial carcinoma (UC) and its correlation with clinical or pathologic features and outcome.

URLhttp://dx.plos.org/10.1371/journal.pone.0103325
DOI10.1371/journal.pone.0103325
Pubmed

http://www.ncbi.nlm.nih.gov/pubmed/25083769?dopt=Abstract